Profile

Synthace Ltd

Synthace is a revenue generating biotech and software company supplying tools and services to optimise bio manufacturing for blue chip clients across all industry sectors. Core to Synthace’s success is its Antha biology operating system that improves bioengineering productivity by connecting hardware and protocols across the laboratory to dramatically improve experimental efficiency.

Status current

Associated Fund Rainbow Seed Fund

Sector Medical / Biotechnology

Website www.synthace.com/

Associated Team Members

Relevant News

Dow AgroSciences, Synthace Research Collaboration to Accelerate Product Development Using High Tech Tools

Synthace and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE:DOW), today…

read more

Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods...

read more

Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult...

The agreement – a £2 million two-year collaboration co-funded by Innovate UK – is to...

read more

Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult...

The agreement – a £2 million two-year collaboration co-funded by Innovate UK – is to...

read more

Watch

Case Studies

Case Study - Synthace

Synthace London-based Synthace provides next-generation software and processes to exponentially improve productivity in bioscience, enabling…

read more

More Companies in Medical / Biotechnology